Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Insmed Inc’s stock clocked out at $26.18, up 0.11% from its previous closing price of $26.15. In other words, the price has increased by $0.11 from its previous closing price. On the day, 1.21 million shares were traded. INSM stock price reached its highest trading level at $26.54 during the session, while it also had its lowest trading level at $25.85.
Ratios:
To gain a deeper understanding of INSM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.75 and its Current Ratio is at 4.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on February 15, 2024, initiated with a Outperform rating and assigned the stock a target price of $42.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $55.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 12 ’24 when Adsett Roger sold 5,251 shares for $28.63 per share. The transaction valued at 150,336 led to the insider holds 148,559 shares of the business.
Flammer Martina M.D. sold 4,667 shares of INSM for $133,616 on Jan 12 ’24. The Chief Medical Officer now owns 106,898 shares after completing the transaction at $28.63 per share. On Jan 10 ’24, another insider, Adsett Roger, who serves as the Chief Operating Officer of the company, sold 3,536 shares for $28.90 each. As a result, the insider received 102,190 and left with 153,810 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSM now has a Market Capitalization of 3889170176 and an Enterprise Value of 4466090496. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.74. Its current Enterprise Value per Revenue stands at 14.633 whereas that against EBITDA is -6.641.
Stock Price History:
The Beta on a monthly basis for INSM is 0.91, which has changed by 0.47909606 over the last 52 weeks, in comparison to a change of 0.2160933 over the same period for the S&P500. Over the past 52 weeks, INSM has reached a high of $32.00, while it has fallen to a 52-week low of $16.81. The 50-Day Moving Average of the stock is -5.14%, while the 200-Day Moving Average is calculated to be 2.03%.
Shares Statistics:
It appears that INSM traded 1.64M shares on average per day over the past three months and 1636070 shares per day over the past ten days. A total of 147.98M shares are outstanding, with a floating share count of 144.65M. Insiders hold about 2.59% of the company’s shares, while institutions hold 101.14% stake in the company. Shares short for INSM as of 1711584000 were 9041518 with a Short Ratio of 5.50, compared to 1709164800 on 8574607. Therefore, it implies a Short% of Shares Outstanding of 9041518 and a Short% of Float of 6.18.
